Prescribing Outside the Exam Room - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prescribing Outside the Exam Room

A DEA case exposes how controlled substances can move outside clinical oversight.

  • By

  • Kathryn Wighton

  • May 5, 2026

  • 2 min

Share

Objective:

To highlight the case of a physician and his son charged with illegally prescribing controlled substances without patient evaluations, emphasizing the lack of legitimate medical purpose.

Key Findings:
  • Prescriptions for drugs like oxycodone-acetaminophen, dextroamphetamine-amphetamine, and alprazolam were issued electronically without patient evaluations.
  • The physician's actions bypassed standard clinical encounters.
  • The case illustrates a gap in real-time oversight of electronic prescribing systems.
Interpretation:

The reliance on professional integrity in prescribing practices is concerning, highlighting the urgent need for adequate real-time safeguards against misuse.

Limitations:
  • The investigation revealed systemic weaknesses in monitoring prescribing authority, with regulatory interventions occurring only after patterns of abuse were identified.
Conclusion:

There is a need for health systems and regulators to enhance real-time monitoring of prescribing practices to prevent exploitation and harm to patients.

Original Source(s)

Prescribing Outside the Exam Room

  • by Kathryn Wighton

  • May 5, 2026

Related Content

CDC Updates Cyclosporiasis Surveillance

More than 5,100 additional reports require further analysis as federal and state partners investigate several outbreaks and work to identify their sources.

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

AI Tool Finds More Long COVID Cases Than Codes

Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.